Jim Cramer Blog

Cramer began his show Friday saying how well his "Four Horsemen of Tech"; Google (GOOG), Research in Motion (RIMM), Apple (AAPL), and Amazon.com (AMZN) are doing. "$80 to $120" stocks list. The stocks were Boeing(BA), Caterpillar(CAT), ConocoPhillips (COP), Air Products(APD), Apache(APA), Terex(TEX), and Energizer(ENR). Cramer admitted that he recommended these stocks too late in the bull market, and that most of these stocks fell after he first recommended them . They are up 5% now, and Cramer thinks that these stocks are the "perfect group." He likes CAT and TEX the best, followed by COP.
Overlooked IPOs: Masimo (MASI). Cramer believes that it has a superior product and a great recurring revenue stream with purchases of disposable parts for the medical sensor they make.
After the lightning round Cramer talked about Allergan (AGN). Cramer said people have a desire to look good, and this stock is in a great position to profit, while moving into traditional medical market. He then had the CEO of the company on the phone to discuss future earnings and sales.
Mad Mail: Cramer answered a few emails. He told viewers to ignore the downgrade on Boeing (BA) since he thinks the stock is going higher. He then answered a question about FiberTower (FTWR), which he doesn't like. In response to another emailer, Cramer said he likes Starent (STAR) because it's an intellectual property play.

Labels: AGN, AMZN, BA, CAT, COP, ENR, GOOG, Jim Cramer, Mad Money, Mad MOney Recap, MASI, RIMM

Nvidia (NasdaqGS: NVDA - News): 'They make the fastest gaming chips. They make the best ones. You buy some and then, if it comes in, you buy some more ... It's a growth stock in the right quarter, at the right time of the year ... NVDA is two thumbs up.'Dynegy (NYSE: DYN - News): 'I like DYN as an asset play, and if the earnings don't hit the number, because of some natural gas realization, come on ('mon-back sound)... step up to the plate...'China Telecom (NYSE: CHA - News)Baidu.com (NasdaqGS: BIDU - News)Nymex (NYSE: NMX - News): 'I believe someone will buy, but I would not recommend a stock just on its takeover ability alone... I would emphasize that, on its earnings - and the earnings here are unbelievable.'Teck Cominco (NYSE: TCK - News): 'People worry that China doesn't have enough demand... that maybe our economy is so slow that it's going to bring down the rest of the world. That's not true. TCK is still a buy. I like it very much.'Lockheed Martin (NYSE: LMT - News): 'I want to buy the defense stocks here. I think it's a terrific opportunity. Don't take your cue from the stocks. Take your cue from the companies, and LMT is doing incredibly well!'General Dynamics (NYSE: GD - News)Raytheon (NYSE: RTN - News)Northrop Grumman (NYSE: NOC - News)Ralcorp Holdings (NYSE: RAH - News): 'I've liked RAH before on the show. I like it now.'ENGlobal (AMEX: ENG - News): 'This is a company that does everything you need to do to produce refining petroleum. It's right. You're right. I'm staying with it. 'Thornburg Mortgage (NYSE: TMA - News): 'I just don't think they're as bad as the bears think.'Allergan (NYSE: AGN - News): ' ... for anything eye... I'm going to send you that way.'
Bearish calls:
Spectranetics (NasdaqGM: SPNC - News): ' ... don't know whether I want to buy it all the way up here... don't buy, don't buy... there are so many that are still down, but it's a good quality company.'Boston Scientific (NYSE: BSX - News)Perfect World (PWRD): 'I am just going to say forget about it... it's too darn hard.'RealNetworks (NasdaqGS: RNWK - News): 'Even thought the guys that run those companies throw really great cocktail parties, and probably wish that I was there, no thank you! (buzzer sounds)... 'Lowe's Companies (NYSE: LOW - News): 'You know, I can't recommend this sector right now - don't buy, don't buy - even though I know they have really easy comparisons. I can't go there. That sector's being too hurt. No to retail.'Advanced Medical Optics (NYSE: EYE - News)Best Buy (NYSE: BBY - News): 'I think there's $3 up, $3 down... which means to me - don't buy, don't buy - not worth playing... '
Published by SeekingAlpha

Labels: AGN, BIDU, CHA, DYN, ENG, GD, Jim Cramer, Lightning Round, LMT, NMX, NOC, NVDA, RAH, RTN, TCK, TMA

Nvidia (NasdaqGS: NVDA - News): 'They make the fastest gaming chips. They make the best ones. You buy some and then, if it comes in, you buy some more ... It's a growth stock in the right quarter, at the right time of the year ... NVDA is two thumbs up.'Dynegy (NYSE: DYN - News): 'I like DYN as an asset play, and if the earnings don't hit the number, because of some natural gas realization, come on ('mon-back sound)... step up to the plate...'China Telecom (NYSE: CHA - News)Baidu.com (NasdaqGS: BIDU - News)Nymex (NYSE: NMX - News): 'I believe someone will buy, but I would not recommend a stock just on its takeover ability alone... I would emphasize that, on its earnings - and the earnings here are unbelievable.'Teck Cominco (NYSE: TCK - News): 'People worry that China doesn't have enough demand... that maybe our economy is so slow that it's going to bring down the rest of the world. That's not true. TCK is still a buy. I like it very much.'Lockheed Martin (NYSE: LMT - News): 'I want to buy the defense stocks here. I think it's a terrific opportunity. Don't take your cue from the stocks. Take your cue from the companies, and LMT is doing incredibly well!'General Dynamics (NYSE: GD - News)Raytheon (NYSE: RTN - News)Northrop Grumman (NYSE: NOC - News)Ralcorp Holdings (NYSE: RAH - News): 'I've liked RAH before on the show. I like it now.'ENGlobal (AMEX: ENG - News): 'This is a company that does everything you need to do to produce refining petroleum. It's right. You're right. I'm staying with it. 'Thornburg Mortgage (NYSE: TMA - News): 'I just don't think they're as bad as the bears think.'Allergan (NYSE: AGN - News): ' ... for anything eye... I'm going to send you that way.'
Bearish calls:
Spectranetics (NasdaqGM: SPNC - News): ' ... don't know whether I want to buy it all the way up here... don't buy, don't buy... there are so many that are still down, but it's a good quality company.'Boston Scientific (NYSE: BSX - News)Perfect World (PWRD): 'I am just going to say forget about it... it's too darn hard.'RealNetworks (NasdaqGS: RNWK - News): 'Even thought the guys that run those companies throw really great cocktail parties, and probably wish that I was there, no thank you! (buzzer sounds)... 'Lowe's Companies (NYSE: LOW - News): 'You know, I can't recommend this sector right now - don't buy, don't buy - even though I know they have really easy comparisons. I can't go there. That sector's being too hurt. No to retail.'Advanced Medical Optics (NYSE: EYE - News)Best Buy (NYSE: BBY - News): 'I think there's $3 up, $3 down... which means to me - don't buy, don't buy - not worth playing... '
Published by SeekingAlpha

Labels: AGN, BIDU, CHA, DYN, ENG, GD, Jim Cramer, Lightning Round, LMT, NMX, NOC, NVDA, RAH, RTN, TCK, TMA

The Unsinkable Jolly Dow
Cramer said the Dow rise of 280 points was "recognition... that maybe something could go right," amid the crisis in housing with "terrible" pin action in other sectors. He added the government can be part of the problem or part of the solution and reiterated his hope Fed Chairman Ben Bernanke will cut interest rates. If the Fed doesn't reduce rates, Cramer says a few other solutions may alleviate the problem somewhat, especially if Treasury Secretary Henry Paulson makes refinancing easier, institutions like Morgan Stanley report a clean bill of health, the Chinese take a major stake in a mortgage company, or if William Buffett rescues a troubled lender. Otherwise, 7 million people could lose their homes and mortgage institutions will have to merge in order to survive.
Allergan (NYSE: AGN - News): "The Costco of Better-Looking Body Parts"
"Even if 7 million people lose their homes, they'll still want to look good," Cramer said, and reiterated his well-known theory that the wheels of Capitalism are greased by the desire for wrinkle-free skin. As bullish Cramer has been on AGN, he says the stock is bigger than he imagined, with a 24% increase in Botox sales, making AGN the most rapid-growing eye company in the world. AGN should rise on the FDA's approval of the use of silicon for breast implants and the company should have a "hammer lock" on the business, according to Cramer. AGN also produces a lap band, which crimps the stomach and facilitates weight loss. Even if there will be widespread misery, Cramer still believes AGN is destined to go higher.

CEO Interview:Curtis Anastasi, NuStar GP Holdings (NYSE: NSH - News)
Anastasio blames weakness in the energy sector for the company's lackluster performance, and says bearishness on the stock is undeserved, since NSH is a "toll taker," does not buy or sell oil directly and is not exposed to high prices. Cramer thanked Anastasio for clarifying NSH's situation, and remarked to viewers," Don't throw everything away."
Published By SeekingAlpha

Labels: AGN, Jim Cramer, Mad Money, NSH

Running Away from Home: Bank Index (BKX)
Cramer would not only get out of housing stocks, he suggests investors may want to leave their homes altogether. This would be a "smart, right, rational" choice if home equity has declined 10%. He would also sell the Bank Index and mortgage companies; "the ripple effects extend pretty far and are pretty ugly."
What Works: Lululemon Athletics (LULU), Garmin (NasdaqGS: GRMN - News), Allergan (NYSE: AGN - News), Under Armour (NYSE: UA - News), Crocks (NasdaqGS: CROX - News), Raytheon (NYSE: RTN - News)
Cramer likes LULU, which was up on one of the market's darkest days. He also recommends GRMN, which rose 8 points and AGN because the "wheels of capitalism are greased by our need to have wrinkle-free skin." Cramer notes UA and CROX are both up and comments they have both been good trades, although he thinks UA will be better in the long run. His favorite defense pick, RTN, was "robbed" of reaching $60 after its report, but Cramer thinks its heading there.
CEO Interview: Jack Hartung, Chipotle Mexican Grill (NYSE: CMG - News)
Cramer asked Jack Hartung how the company is dealing with rising food prices. "It was worse by 100 basis points this quarter," he said, but stressed the rising prices are not affecting business because CMG uses higher quality food to begin with. Hartung mentioned two factors which are creating growth for CMG; "We look at the quality of real estate we can secure and the quality of managers we're developing." The company motivates managers by paying them a $10,000 bonus for every crew person they develop to become a manager. Cramer predicts the stock will rise tommorrow and would only sell when CMG has has three analyst upgrades (currently CMG has one upgrade).
Published By SeekingAlpha

Labels: AGN, CMG, CROX, GRMN, Jim Cramer, Mad Money, RTN, UA

Bullish Calls:
Allergan (NYSE: AGN - News)LifeCell (NasdaqGS: LIFC - News): 'I'm not going to run away from MRX now. I think Jonas Shaknai can deliver. I think you've got a good one in LIFC.'Synchronoss Technologies (NasdaqGM: SNCR - News): 'This is just the kind of consistent service business I like ... I think Goldman gave it away.'Level 3 Communications (NasdaqGS: LVLT - News)Wal-Mart (NYSE: WMT - News): ' ... the turn is at hand and, if Lee Scott leaves... plus 5... 'Time Warner (NYSE: TWX - News): 'They're going to break the company up, because it's too difficult to understand... I told my friend, Regis Philbin, recently to please not give up on TWX.'Tellabs (NasdaqGS: TLAB - News): 'Someone has to acquire them ... I am going to violate my rules... and I am going to say ... own TLAB... I hope that I don't have to pay for that one.'Celgene (NasdaqGS: CELG - News): 'I am reiterating that, if you want regular bio, you go with Celgene.'Nastech Pharmaceutical (NasdaqGM: NSTK - News): ' ... if you want a little speculative, you go with Nastech.'
Bearish calls:
Target (NYSE: TGT - News): 'I would ring the register for TGT...'Ryanair Holdings (NasdaqGS: RYAAY - News): 'I think that oil's going to $80 a barrel ... I think this group is just really bad. Sell, sell, sell!...'Genentech (NYSE: DNA - News): ' I am saying ix-nay on your DNA, unfortunately... Sell, sell, sell!... '
Published By SeekingAlpha

Labels: AGN, CELG, DNA, Jim Cramer, LIFC, Lightning Round, LVLT, Mad Money, NSTK, RYAAY, SNCR, TGT, TLAB, TWX, WMT

Winner CEO: Fred Hassan, Schering-Plough (NYSE: SGP)
Cramer said he is dedicating a weekly series to "transformational CEOs" who have "managed to turn around dead franchises into living, thriving ones." In 2003, Fred Hassan took the helm of SGP, and replaced Richard Kogan, who left the company with $1 billion in debt and was "the worst of the worst" among CEOs. Since then, the stock has doubled and Fred Hassan has led the company through ten straight quarters of double-digit sales growth. Currently, SGP has a pipeline full of new drugs and Cramer believes the stock will go higher.
Not a Chicken on Earnings: Buffalo Wild Wings (NasdaqGS: BWLD)
One of the top conference calls this season was BWLD, and Cramer believes its "excellent" CEO Sally Smith has the company under control. Same store sales were up 8.7%, and earnings per share increased 58% year over year. In addition, the cost of the BWLD's food is not being affected by rising corn prices. Cramer feels the company will underpromise and overdeliver, is a regional-to-national story and is a long way from its saturation point.
A Healthy Choice: Chipotle Mexican Grill (NYSE: CMG)
Another winning conference call was that of CMG, whose CEO, Steve Ells, expressed confidence that CMG is outperforming its competitors. After the call, the stock reached a new high of $83. Steve Ells commented CMG is not wasting money and resources on revamping its menu or coming up with unusual marketing techniques or themes, but is featuring "green" food from naturally raised beef and cows which have not been treated with synthetic growth hormones. The company saw a 46.2% increase in earnings per share, and raised its guidance. Cramer is bullish on CMG.
CEO Interview: Medicis Pharmaceutical (NYSE: MRX) Jonah Shacknai with Allergan (NYSE: AGN)
Jonah Shacknai is skeptical that investment houses and analysts have MRX's numbers right, since the company does not publish numbers. He adds MRX raised its guidance. Shacknai discussed Solodyn, a drug which has been successful and has room to grow. Another drug, Restylane, is safe and effective for treating wrinkles, has done well overseas and should perform well in the U.S, he said. Cramer said he likes MRX along with AGN.

Labels: AGN, BWLD, CMG, Jim Cramer, Mad Money, MRX, SGP

At Your Laser: Ionatron (NasdaqGM: IOTN)
One stock Cramer likes for the CNBC Million Dollar Portfolio Challenge and even more for an actual speculative play is IOTN which produces lasers. The company makes both lethal and non-lethal lasers which are effective in locating and detonating explosive devices. The stock fell from $14 to $5 last May when it was passed up for a military contract, but IOTN has improved its technology to fit devices on existing vehicles, and Cramer predicts it will get the contract this time around and squeeze the shorts. He would do homework before buying the stock.

A Roll of the Dice: Penn National Gaming Inc. (NasdaqGS: PENN)
Next on Cramer's list of attractive takeover targets for private equity firms is PENN, a gaming company which is not among the most famous names, but gives "regular people all over the country the opportunity to foolishly flush their hard-earned money down the slots." The purchase of Harrah's is proof that private equity firms would consider a gaming play, and since PENN is smaller and cheaper, it would be easier to purchase. He predicts PEN will be taken over at a premium; "I think this one could make you over 30%, if you play your cards right," Cramer said.

Game Plan for the Coming Week: Vulcan Materials (NYSE: VMC - News), Avon (NYSE: AVP - News), Quest (NYSE: Q - News), Procter & Gamble (NYSE: PG - News), Medco Health (NYSE: MHS - News), Wyndham Hotels (NYSE: WYN - News), General Cable (NYSE: BGC - News), Chipotle Mexican Grill (NYSE: CMG - News), Buffalo Wild Wings (NasdaqGS: BWLD), Allergan (NYSE: AGN - News), Transocean (NYSE: RIG - News), Trinity Industries (NYSE: TRN - News), American Railcar (NasdaqGS: ARII), Celgene (NasdaqGS: CELG), Charter Communications (NasdaqGM: CHTR), Level 3 (NasdaqGS: LVLT), Anderson's (NasdaqGS: ANDE), Estee Lauder (NYSE: EL - News), KBR Inc. (NYSE: KBR - News)
Monday: Cramer said the best strategy for the coming week is to grab winners ahead of their reports, and added there are so many great names, it may be hard to choose. On Monday, he likes VMC, up 82% with room to run.
Tuesday: Cramer has freed AVP from permanent residence on his Sell Block segment and predicts AVP will hit a "homerun." The stock is up a little over a dollar and has great BRIC exposure. Although Quest has had a 43% gain, Cramer is still backing it, and anticipates the announcement of a buyback or a dividend increase. He thinks PG will join the ranks of Pepsi and Coke thanks to its international success. MHS is "a member of the pantheon of consistency if there ever was one," since it is leveraged to drugs going generic and off patent. Cramer likes WYN as a baby boomer play and expects rosy numbers. After the bell, GC is a pick Cramer believes will go higher, although it has had a recent run-up. Concerning CMG and BWLD, he said, "I praise these stocks endlessly and correctly. I'm not stopping now."
Wednesday: Although Allergan is up 23% and "everyone is freaking out about competition," Cramer is not worried. He still likes RIG, but since it has risen 11%, Cramer would wait for it to come in a bit. He is also bullish on rail stocks TRN and ARII.
Thursday: Cramer says CELG has been "perking along" up from under $55 in February to over $61 now and predicts it will rally. He would sell CHTR before the quarter and buy it back. He reiterated his bullishness on LVLT and noted its strong organic growth and improved balance sheet. Cramer is looking forward to witnessing a short squeeze when ANDE reports; "We're going into ethanol harvest season. What are these people thinking? Go long, not short." He also likes EL as "the quintessential weak-dollar play."
Friday: Cramer suggests viewers invest in KBR "the only overlooked infrastructure play left on Earth," and says KBR will follow other giants in the sector, which have rallied.
Mad Mail, Cummins Engine (NYSE: CMI - News): Cramer congratulates those viewers who heeded his call to buy CMI and made some money; "We really nailed that one," he said.
Published By SeekingAlpha

Labels: AGN, AVP, BGC, CMI, EL, IOTN, Jim Cramer, KBR, Mad Money, MHS, PENN, PG, Q, RIG, TRN, VMC, WYN

Bullish calls:
Sirius Satellite Radio (NasdaqGS: SIRI): 'Perhaps someone might want to ask me about SIRI, which I think could just get a bump of 10%, because of some activities in radio...'Mattel (NYSE: MAT - News): 'I feel that MAT goes higher ... How about this? If you have 200 shares, take off 50, but let that run on a fundamental basis, because it's real good.'Hasbro (NYSE: HAS - News)CVS (NYSE: CVS - News): ' ... they got this Caremark. It's a great move ... CVS - best in show. Really smart. Ended up getting it cheap. I'm not backing away from CVS. No. If anything - down a dollar - I'm pulling the trigger.'Express Scripts (NasdaqGS: ESRX): 'I've been buying ESRX ... Why? Because I think Walgreens has to do a me-too (buy ESRX because CVS bought Caremark).'Rochester Medical (NasdaqGM: ROCM): 'Unbelievably good baby-boomer play. I say stick with it. Do not can it until you get to $30 smackers!'Zimmer (NYSE: ZMH - News)Allergan (NYSE: AGN - News)Color Kinetics (NasdaqGM: CLRK): 'CLRK makes this really cool lighting system ... I think CLRK is the best-in-show of the lighting group. That's what you want to be in.'Bank of Nova Scotia (NYSE: BNS - News): 'BNS? ...They are going to own - I am not kidding - they are going to own the Caribbean. BNS is the best-run bank in Canada.'Medco Health (NYSE: MHS - News): 'MHS, down $4 bucks from a high is so fantastic...'Yamana Gold (NYSE: AUY - News): 'We're going to go to AUY! Still, after a double, I am still recommending AUY. That's the best in show ('mon-back sound).'International Securities Exchange (NYSE: ISE - News): 'All right, every one of these is a takeover target.'IntercontinentalExchange (NYSE: ICE - News): 'I am liking ICE - the Intercontinental Exhange - down $40 from its high.'Intuitive Surgical (NasdaqGS: ISRG): 'The only one in the medical space that's left is ISRG. The stock grows at 35%, It has the ability to go up another 30-40 points. I want to buy ISRG. I like that stock very much.'Las Vegas Sands (NYSE: LVS - News): 'Oh, you know I like that company. That is really well-run. I've liked it for 50 points.'Mueller Water (NYSE: MWA - News): 'I just got their annual report. I think it looks real good. I've got to tell you, I'm a believer down here in water infrastructure.'
Bearish calls:
US Gold (AMEX: UXG - News): 'No. No. You know, we're not going to go to Nevada and find a lot of gold anymore. We're going to go to Latin America. We're going to go to South America.'J2 Global Communications (NasdaqGS: JCOM): ' ... this has been a very hard stock for me to get a line on, frankly. I have not understood why it keeps going higher ... 'don't buy, don't buy'Mannatech (NasdaqGS: MTEX): 'Nutritional supplements. A good business, but I have burned people in MATK, so I want to be very careful, and, again, I'm going to have to resort to the 'don't buy' button.'Smith & Wesson (NasdaqGS: SWHC): 'I'm sticking with another 'don't buy.'BB&T (NYSE: BBT - News): 'No. No. I don't like the regional banks. Sell, sell, sell!'Valero Energy (NYSE: VLO - News): 'At $69... At this price, I'm a register ringer. I can't take the pain. I'd rather be in an integrated.'
Published By SeekingAlpha

Labels: AGN, AUY, BBT, BNS, CVS, HAS, ICE, ISE, Jim Cramer, Lightning Round, LVS, Mad Money, MAT, MHS, SIRI, UXG, VLO, ZMH

Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Dow Chemical (NYSE:DOW - News). DOW's PowerRating is 6.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Vanda Pharmaceuticals (NasdaqGM:VNDA - News) & Advance America (NYSE:AEA - News). VNDA's PowerRating is 8, and AEA's PowerRating is 6.
Stocks Down 10% or More: These are stocks that have lost 10% or more over the past five days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that have lost 10% or more over the past five days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Stride Rite (NYSE:SRR - News). SRR's PowerRating is 7.
Bearish
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge. Historically, these stocks have provided traders with a significant edge.
Allergan (NYSE:AGN - News). AGN's PowerRating is 4.
2-Period RSI Above 98: These are stocks that have a 2-period RSI reading above 98 and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving with a 2-period RSI reading above 98 have shown negative returns, on average, 1-day and 1-week later. Historically, these stocks have provided traders with a significant edge.
Quest Diagnostic (NYSE:DGX - News). DGX's PowerRating is 4.
Stocks Up 10% or More: These are stocks that have gained 10% or more over the past five days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that have gained 10% or more over the past five days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge.
NutriSystem (NasdaqGS:NTRI - News). NTRI's PowerRating is 2.
PowerRatings are courtesy of PowerRatings.net

Labels: AEA, AGN, DGX, DOW, Hot Stocks, NTRI, SRR, VNDA

Labels: AGN, AMR, ATI, CAL, CFC, HP, Jim Cramer, Lightning Round, Mad Money, NEW, RIG, ZMH

Acco Brands Corp. (NYSE:ABD - News) was downgraded to neutral from outperform at Credit Suisse.
Align Technology (NasdaqGM:ALGN - News) was downgraded to market perform from outperform at Barrington Research, citing valuation.
Allergan Inc. (NYSE:AGN - News) reported fourth-quarter earnings of $136.8 million, or 89 cents a share, down from a year-ago profit of $140.1 million, or $1.03 a share. On an adjusted basis, excluding certain charges, the company earned $156.5 million, or $1.02 a share, in the latest quarter. The average estimate of analysts polled by Thomson Financial was for a profit of $1.02 a share in the December period. Looking ahead, the Irvine, Calif., medical and healthcare products company said it expects adjusted earnings of $4.27 to $4.31 a share for fiscal 2007 on total product net sales of between $3.46 billion and $3.63 billion. For the first quarter, it sees adjusted earnings of 88 to 90 cents a share on total product net sales of between $830 million and $850 million. Wall Street's current consensus estimates are for earnings of $4.31 a share for the year and 98 cents a share for the March quarter.
Allstate (NYSE:ALL - News) reported a 17% increase in fourth-quarter profit, but the insurer's results missed analyst estimates and the company said it will stop giving profit forecasts.
Buckeye Technologies' (NYSE:BKI - News) said second-quarter net income more than doubled to $3.82 million, or 10 cents a share, from $1.85 million, or 5 cents a share, a year earlier, as the company cut costs. The Memphis cellulose and absorbent products company's sales dropped 1.9% to $184.7 million from $188.3 million. Costs of goods sold fell 4.2% to $155.7 million from $162.5 million. On average, analysts expected the company to post earnings of 11 cents a share and revenue of $199.5 million, according to Thomson Financial.
Calumet Specialty Products (NasdaqGM:CLMT - News) was downgraded to neutral from buy at Goldman Sachs.
Celestica (NYSE:CLS - News) shares fell after the company said its fourth-quarter net loss widened to $60.8 million, or 27 cents a share, from $28.2 million, or 12 cents a share, as costs of sales rose. The most recent quarter's results include a $30 million net charge related to an increase in inventory at a Mexico facility and a $59 million restructuring charge. Excluding amortization of intangible assets, among other items, the Canada-based provider of electronics manufacturing services posted per-share earnings of 3 cents vs. 13 cents in the prior year. Revenue rose 9% to $2.26 billion from $2.08 billion. The company sees an adjusted first-quarter per-share loss of 4 to 15 cents, on revenue of $1.7 billion to $1.9 billion. The company was also downgraded to underperform from peer perform at Bear Stearns.
U.S.-listed shares of Chinese companies fell, tracking steep losses in their home market after a senior legislator said the market may be overheated after a 130% gain in 2006. The comments by Cheng Siwei, vice-chairman of the standing committee of the National People's Congress, in an interview with the Financial Times, raised concerns the Chinese government may take official action to cool speculation after the market hit a record high last week. Chinese ADRs such as Guangshen Railway (NYSE:GSH - News), China Mobile (NYSE:CHL - News), Aluminum Corp. China (NYSE:ACH - News), China Life Insurance (NYSE:LFC - News) and Sinopec (NYSE:SNP - News) were all markedly lower.
Electronics For Imaging's (NasdaqGS:EFII - News) fourth-quarter earnings fell 38% to $7.08 million, or 12 cents a share, from $11.4 million, or 18 cents a share, a year earlier. On a non-GAAP basis, the Foster City, Calif., provider of digital controllers said earnings fell to $22.6 million, or 35 cents a share, from $23.1 million, or 36 cents a share. Revenue rose 5.8% to $153.9 million from $145.4 million in the year-ago period. The company expects to delay its Form 10-K filing for 2006 due to its ongoing stock-option grant investigation. The company sees first-quarter non-GAAP earnings of 25 to 27 cents a share on revenue of $140 million to $143 million.
Haemonetics' (NYSE:HAE - News) shares tumbled after the maker of automated blood processing systems provider forecast earnings of adjusted $2.05 to $2.17 per share for fiscal 2007 with revenue expected to rise between 7% and 9%. The company said this view reflect expectations for continued sales declines in its Japanese business.
Juniper Networks Inc. (NasdaqGS:JNPR - News) reported fourth-quarter revenue rose 4% to $595.8 million, from $575.5 during the same period one year ago. The sales figure slightly topped the estimates of Wall Street analysts surveyed by Thomson Financial, who had forecast $593 million.
Key Tronic (NasdaqGM:KTCC - News) shares dropped after the Spokane, Wash., provider of electronic manufacturing services posted a second-quarter profit of $300,000, or 3 cents a share, down from a profit of $1 million, or 10 cents a share, last year. The latest results include a charge of $940,000 related to a customer unexpectedly declaring bankruptcy in December. Key Tronic also said that new customer programs weren't enough to offset reduced demand from certain existing customers in the latest quarter.
Manitowoc Co. (NYSE:MTW - News) reported fourth-quarter net earnings of $43.9 million, or 69 cents a share, compared with $18.2 million, or 30 cents a share, in the same period last year, on strong revenues in the company's crane segment.
NutriSystem (NasdaqGS:NTRI - News) shares fell after the Horsham, Pa., provider of weight management and fitness products and services forecast first-quarter earnings of 82 to 86 cents a share on revenue of between $200 million and $210 million. Wall Street's current consensus estimate is for a profit of 94 cents a share in March period on revenue of $214 million.
Public Service Enterprise Group (NYSE:PEG - News) said its fourth-quarter earnings from continuing operations fell to $173 million, or 69 cents a share, from $227 million, or 92 cents, a year earlier. The average earnings estimate of seven analysts surveyed by Thomson Financial was 74 cents a share.
Regeneron Pharmaceuticals (NasdaqGM:REGN - News) was initiated with an average rating at Caris & Co.
Published By MarketWatch

Labels: ABD, ACH, AGN, ALGN, ALL, BKI, CHL, CLMT, CLS, EFII, GSH, HAE, JNPR, KTCC, LFC, MTW, NTRI, PEG, REGN, SNP

Bullish calls:
Denny's (NASDAQ: DENN - News): ‘ is so right ... a restructuring story ... paying off debt ... earnings going to go up. Getting to where it should have been two years ago. Two thumbs up, way up.’Mentor (NYSE: MNT - News): ‘There's room for Mentor, but it is not as good as AGN.’Allergan (NYSE: AGN - News)MasterCard (NYSE: MA - News): ‘Pull the trigger [buy] . ... There's nothing wrong, we just found out JPMorgan had 17% growth in the credit card business ... I'm staying bullish ... been bullish for 50 points ... not backing away.’Immucor (NASDAQ: BLUD - News): ‘This company does terrific laboratory work. ... Well-run, it's a good company ... fabulous growth. Sells about one times earnings. What's not to like?’Global Sources (NASDAQ: GSOL - News): ‘You know, I like this company. You know, it's an Internet play ... hit 52-week high ... but I'm not backing away.’Duke Energy (NYSE: DUK - News): ‘They've restructured the company ... so well-run ... I like the utilities here, and Duke is one of the best in the country.’Genentech (NYSE: DNA - News)
Bearish calls:
Ship Finance International (NYSE: SFL - News):‘Too many very large carriers being built. That could drive the rates down. They may not be able to pay the dividend. Put me in the Don'tBuy" camp.’Valero Energy (NYSE: VLO - News): ‘Mutual funds are piling out of Valero. ... Even though it's dirt cheap, I don't want you to buy Valero.’MGM Mirage (NYSE: MGM - News): 'Ring the Register!’MGI Pharma (NASDAQ: MOGN - News)

Labels: AGN, BLUD, DENN, DNA, DUK, GSOL, Jim Cramer, Lightning Round, MA, Mad Money, MGM, MNT, MOGN, SFL, VLO

Bullish calls:
Dell (NASDAQ: DELL - News): 'I have to tell you, you don't sell any of these PC stocks ahead of the Vista launch. You sell them one day after the Vista launch, and then I will do the sell, sell, sell."eBay (NASDAQ: EBAY - News): 'I am a minority of one. I genuinely think that EBAY is a good stock. ...said that they're buying Stub Hub, which I think is a brilliant acquisition. I'm not backing away; I'm backing the truck up for EBAY.'Boeing (NYSE: BA - News): 'People keep wanting to get off the BA horse. They're wrong! Monster quarter coming. AirBus still can't make the planes, for heaven's sake. I want to continue to buy BA, until it gets to $100.'Boston Scientific (NYSE: BSX - News): 'The stock has been soggy now for about 80 cents ... But! That means it's an opportunity. And, yes! BSX - ever since we recommended it a dollar ago - has been on a slow creep up. I think it goes to $20 bucks, and then let's reconfigure.'Google (NASDAQ: GOOG - News): ' This company's going to have a good quarter. Notice that - every time it creeps up on the up days, I want to own this stock under $500. My price target remains in the $600 level. It will get there. Do not lose faith.'Blockbuster (NYSE: BBI - News)Rite Aid (NYSE: RAD - News)Crown Castle (NYSE: CCI - News): 'I'd swap out of C and move into CCI.'Advanced Micro Devices (NYSE: AMD - News): 'I think AMD's cheap ... I think AMD is better than Intel. I want to own AMD, ahead of the Vista launch.'Allegheny Technologies (NYSE: ATI - News): 'Those of you that are still looking for a new name, ATI has pulled back $10. Bring it in, bring it in. Buy, buy, buy!'Cisco (NASDAQ: CSCO - News): ' ... one of my growth stocks of the year.'Lundin Mining (AMEX: LMC - News): ' I recommended this stock because I think it's got good fundamentals, and I think it can get a takeover. I'm not backing away from that. But ... commodities are in free fall right now ... Give it a little room, and then buy, because that thesis isn't going away. It's just right now dormant.'Allergan (NYSE: AGN - News): 'AGN has been going down off of a CIBC report that I think is gravely mistaken, saying that the breast implant business is not going to be good for AGN ... AGN's got Juvaderm ... AGN's got Botox ... I need you to buy AGN.'Hewlett-Packard (NYSE: HPQ - News): 'The only PC stock you can own for the whole year is HPQ. Because Mark Hurd is better than the average bear.'Lowe's (NYSE: LOW - News): 'I much prefer LOW. LOW's is better than Home Depot.'Monsanto (NYSE: MON - News): 'The analysts continue to hate it. I continue to like it. I like all the hybrid new corn that they've got.'
Bearish calls:
Sirenza Microdevices (NASDAQ: SMDI - News): 'SMDI is radio frequency for the SIRI [Sirius Satellite Radio] satellites of the world ... I want to steer clear. I am telling you, sell SMDI and never look back.'Brocade (NYSE: BRC - News): 'I think BRCD's had a nice run and it's time to move on. They did that good merger with MacData... 'Citigroup (NYSE: C - News): ' ... it's still run by a lawyer, and we don't really care for banks that are run by lawyers ... C is not going to hurt you. I just don't think it's a great stock to own. Let's cut back a little.'Anadigics (NASDAQ: ANAD - News): 'No on radio frequency names; it's too competitive and I don't want to be there. Sell, sell, sell!'H&R Block (NYSE: HRB - News): 'No. Sell, sell, sell. Permanent sell. Plus, they've run afoul of Governor Spitzer. No.'Home Depot (NYSE: HD - News): 'No, no. I don't want HD, even though I like it long-term.'RTI Metals (NYSE: RTI - News): 'I would schnitzel out of RTI, and go into ATI.'
Published by SeekingAlpha

Labels: AGN, AMD, ATI, BA, BBI, BSX, CCI, CSCO, DELL, Ebay, GOOG, HPQ, Jim Cramer, LMC, LOW, Mad Money, MON, RAD

Allergan (NYSE:AGN - News) said the Food and Drug Administration has issued an approvable letter for Combigan, a treatment to reduce elevated intraocular pressure. The company said the FDA has suggested an additional confirmatory study to address certain questions posed, and that Allergan has already commenced a clinical study that addresses the questions.
Electroglas Inc. (NASDAQ:EGLS - News) said its second-quarter net loss narrowed to $3.23 million, or 12 cents a share, from a net loss of $5.3 million, or 24 cents a share, during the same period in the prior year. The San Jose, Calif.-based chip testing company said quarterly revenue rose to $12.6 million from $9.88 million in the prior year. For the third quarter, Electroglas sees sales of $10 million to $12 million.
GTSI Corp. (NASDAQ:GTSI - News) on Friday reported results for its second and third quarters, and said it expects to file its Form 10-K/A and Form 10-Q/A today with the Securities and Exchange Commission, which should make it compliant with Nasdaq listing requirements. For the third quarter ended Sept. 30 the company reported a net loss of $3.4 million, or 35 cents a share, as sales fell 9.7% to $241.6 million. For the second quarter ended June 30, the Chantilly, Va., information technology company posted income of $944,000, or 10 cents a share, as sales rose 1% to $180.9 million. Since August, GTSI has been evaluating its financial records for the periods of 2003, 2004, 2005 and the first quarter of 2006, resulting in restatements for those periods.
Qualcomm (NASDAQ:QCOM - News) said it now expects first-fiscal-quarter earnings per share, excluding items, of 41 cents to 42 cents, compared with its prior outlook of 42 cents to 44 cents. The company added that it now expects quarterly revenue to be at the high end of its prior view of $1.98 billion to $2.08 billion.
Shire and New River Pharmaceuticals (NASDAQ:NRPH - News) said the U.S. Food and Drug Administration has given the firms a second approvable letter on Vyvanse, formerly known as NRP 104, to treat attention deficit hyperactivity disorder. No additional studies have been requested by the FDA as a condition for approval in what the companies called a "routine" request for data, and they still plan a second-quarter 2007 launch. The FDA has proposed the drug is classified as a Schedule II controlled substance, and the drug will be available in three once-daily dosages.
Solectron Corp. (NYSE:SLR - News) said first-quarter net income fell, as the company recorded a $34.6 million restructuring charge, to $6 million, or a penny a share, from $24 million, or 3 cents a share, during the same period in the prior year. Excluding items, quarterly per-share income rose to 6